Physician profile
Johar Raza
NPI 1679913958
$8,197.69
in general payments reported to CMS, 2019-2025
13 companies · $1,815 in 2025
The $1,815 reported for 2025 was more than what 78% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,893 · 2020: $172 · 2021: $4,191 · 2022: $127 · 2025: $1,815.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $789 · Consulting Fee: $755 · Travel and Lodging: $270.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $789.09 |
| Consulting Fee | $755.04 |
| Travel and Lodging | $270.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $3,874.78 | 2021-2022 | |
| Boston Scientific Corporation | $2,016.02 | 2019-2025 | Ams 800 Artificial Urinary Sphincter, Ams 700 |
| Edap Technomed INC | $1,332.01 | 2025 | |
| Ambu INC. | $281.02 | 2020-2025 | |
| Cook Medical LLC | $136.90 | 2021 | |
| Calyxo, INC. | $130.58 | 2025 | Cvac Aspiration System |
| Janssen Scientific Affairs, LLC | $127.53 | 2025 | |
| Merck Sharp & Dohme LLC | $92.59 | 2021 | |
| Astellas Pharma US INC | $78.58 | 2021 | |
| Ferring Pharmaceuticals INC. | $76.56 | 2025 | Adstiladrin |
| Myovant Sciences INC. | $20.78 | 2021 | |
| Coloplast Corp | $16.66 | 2022 | |
| Genentech, INC. | $13.68 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Johar Raza listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.